Visual	visual	O	DISEASE	OTHERS	I
hallucinations	hallucinations	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
zonisamide	zonisamide	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Zonisamide	zonisamide	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
broad-spectrum	broad-spectrum	O	O	O	O
antiepileptic	antiepileptic	O	O	O	O
drug	drug	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
treat	treat	O	O	O	O
various	various	O	O	O	O
types	types	O	O	O	O
of	of	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Although	although	O	O	O	O
visual	visual	O	DISEASE	OTHERS	I
hallucinations	hallucinations	O	DISEASE	OTHERS	I
have	have	O	O	O	O
not	not	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
as	as	O	O	O	O
an	an	O	O	O	O
adverse	adverse	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
agent	agent	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
describe	describe	O	O	O	O
three	three	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
experienced	experienced	O	O	O	O
complex	complex	O	O	O	O
visual	visual	O	DISEASE	OTHERS	I
hallucinations	hallucinations	O	DISEASE	OTHERS	I
and	and	O	O	O	O
altered	altered	O	O	O	O
mental	mental	O	O	O	O
status	status	O	O	O	O
after	after	O	O	O	O
zonisamide	zonisamide	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
was	was	O	O	O	O
begun	begun	O	O	O	O
or	or	O	O	O	O
its	its	O	O	O	O
dosage	dosage	O	O	O	O
increased	increased	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
three	three	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
diagnosed	diagnosed	O	O	O	O
earlier	earlier	O	O	O	O
with	with	O	O	O	O
epilepsy	epilepsy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
their	their	O	O	O	O
electroencephalogram	electroencephalogram	O	O	O	O
(	(	O	O	O	O
EEG	eeg	O	O	O	O
)	)	O	O	O	O
findings	findings	O	O	O	O
were	were	O	O	O	O
abnormal	abnormal	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
monitoring	monitoring	O	O	O	O
,	,	O	O	O	O
visual	visual	O	DISEASE	OTHERS	I
hallucinations	hallucinations	O	DISEASE	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
correlate	correlate	O	O	O	O
with	with	O	O	O	O
EEG	eeg	O	O	O	O
readings	readings	O	O	O	O
,	,	O	O	O	O
nor	nor	O	O	O	O
did	did	O	O	O	O
video	video	O	O	O	O
recording	recording	O	O	O	O
capture	capture	O	O	O	O
any	any	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
described	described	O	O	O	O
events	events	O	O	O	O
.	.	O	O	O	O

None	none	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
experienced	experienced	O	O	O	O
visual	visual	O	DISEASE	OTHERS	I
hallucinations	hallucinations	O	DISEASE	OTHERS	I
before	before	O	O	O	O
this	this	O	O	O	O
event	event	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
only	only	O	O	O	O
recent	recent	O	O	O	O
change	change	O	O	O	O
in	in	O	O	O	O
their	their	O	O	O	O
treatment	treatment	O	O	O	O
was	was	O	O	O	O
the	the	O	O	O	O
introduction	introduction	O	O	O	O
or	or	O	O	O	O
increased	increased	O	O	O	O
dosage	dosage	O	O	O	O
of	of	O	O	O	O
zonisamide	zonisamide	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

With	with	O	O	O	O
either	either	O	O	O	O
discontinuation	discontinuation	O	O	O	O
or	or	O	O	O	O
decreased	decreased	O	O	O	O
dosage	dosage	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
drug	drug	O	O	O	O
the	the	O	O	O	O
symptoms	symptoms	O	O	O	O
disappeared	disappeared	O	O	O	O
and	and	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
recur	recur	O	O	O	O
.	.	O	O	O	O

Further	further	O	O	O	O
observations	observations	O	O	O	O
and	and	O	O	O	O
reports	reports	O	O	O	O
will	will	O	O	O	O
help	help	O	O	O	O
clarify	clarify	O	O	O	O
this	this	O	O	O	O
adverse	adverse	O	O	O	O
effect	effect	O	O	O	O
.	.	O	O	O	O

Until	until	O	O	O	O
then	then	O	O	O	O
,	,	O	O	O	O
clinicians	clinicians	O	O	O	O
need	need	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
possible	possible	O	O	O	O
complication	complication	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
zonisamide	zonisamide	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

